AT1 receptor-activated signaling mediates angiotensin IV-induced renal cortical vasoconstriction in rats

American Journal of Physiology - Renal Physiology

Volumn 290, Issue 5, 2006, Pages

  Li, Xiao C ^a   Campbell, Duncan J ^b   Ohishi, Mitsuru ^c   Yuan, Shao ^a   Zhuo, Jia L ^a  

^a HENRY FORD HOSPITAL   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Angiotensin IV; Angiotensin type 1 receptor; Angiotensin type 4 receptor; Mitogen activated protein kinases; Renal cortical blood flow

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; LOSARTAN; PHOSPHOLIPASE C; ANGIOTENSIN II, DES ASP(1) DES ARG(2) ILE(5); ANGIOTENSIN II, DES-ASP(1)-DES-ARG(2)-ILE(5)-; DRUG DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DATA ANALYSIS; ENZYME PHOSPHORYLATION; KIDNEY BLOOD FLOW; KIDNEY CORTEX; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RENAL ARTERY; VASOCONSTRICTION; ANIMAL; BLOOD FLOW; CULTURE TECHNIQUE; DOSE RESPONSE; DRUG EFFECT; KIDNEY MEDULLA; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULARIZATION;

ANGIOTENSIN II; ANIMALS; CELL CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; KIDNEY CORTEX; KIDNEY MEDULLA; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; REGIONAL BLOOD FLOW; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

EID: 33646511599     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00221.2005     Document Type: Article

References (44)

1. Abrahamsen CT, Pullen MA, Schnackenberg CG, Grygielko ET, Edwards RM, Laping NJ, and Brooks DP. Effects of angiotensin II and IV on blood pressure, renal function, and PAI-1 expression in the heart and kidney of the rat. Pharmacology 66: 26-30, 2002.
2. Albiston AL, McDowall SG, Matsacos D, Sim P, Clune E, Mustafa T, Lee J, Mendelsohn FA, Simpson RJ, Connolly LM, and Chai SY. Evidence that the angiotensin IV [AT(4)] receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem 276: 48623-48626, 2001.
3. Ardaillou R and Chansel D. Synthesis and effects of active fragments of angiotensin II. Kidney Int 52: 1458-1468, 1997.
4. Berk BC and Corson MA. Angiotensin II signal transduction in vascular smooth muscle cells: role of tyrosine kinase. Circ Res 80: 607-616, 1997.
5. Blair-West JR, Coghlan JP, Denton DA, Funder JW, and Scoggins BA. The effect of the heptapeptide (2- 8) and hexapeptide (3- 8) fragments of angiotensin II on aldosterone secretion. J Clin Invest 32: 575-578, 1971.
6. Cain MD, Catt KJ, and Coghlan JP. Immunoreactive fragments of angiotensin II in blood. Nature 223: 617-618, 1969.
7. Campbell DJ and Kladis A. Simultaneous radioimmunoassay of six angiotensin peptides in arterial and venous plasma of man. J Hypertens 8: 165-172, 1990.
8. Campbell DJ, Lawrence AC, Towrie A, Kladis A, and Valentijin AJ. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension 18: 763-773, 1991.
9. Campbell DJ, Krum H, and Murray DS. Losartan increases bradykinin levels in hypertensive humans. Circulation 111: 315-320, 2005.
10. Carey RM and Siragy HM. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 24: 261-271, 2003.
11. 1 receptors in the rat. Am J Physiol Endocrinol Metab 274: E115-E123, 1998.
12. 2+ in mesangial cells. Eur J Pharmacol 414: 165-175, 2001.
13. Chansel D, Czekalski S, Vandermeersch S, Ruffet E, Fournie-Zaluski M, and Ardaillou R. Characterization of angiotensin IV-degrating enzymes and receptors on rat mesangial cells. Am J Physiol Renal Physiol 275: F535-F542, 1998.
14. Chen JK, Zimpelmann J, Harris RC, and Burns KD. Angiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells. Am J Physiol Renal Physiol 280: F980-F988, 2001.
15. Coleman JK, Krebs LT, Hamilton TA, Ong B, Lawrence KA, Sardinia MF, Harding JW, and Wright JW. Autoradiographic identification of kidney angiotensin IV binding sites and angiotensin IV-induced renal cortical blood flow changes in rats. Peptides 19: 269-277, 1998.
16. de Gasparo M, Catt KJ, Inagami T, Wright JW, and Unger T. International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472, 2000.
17. Dulin N, Madhum ZT, Chang CH, Berti-Mattera L, Dickens D, and Douglas JG. Angiotensin IV receptors and signaling in opossum kidney cells. Am J Physiol Renal Fluid Electrolyte Physiol 268: F644-F652, 1995.
18. Fitzgerald SM, Evans RG, Bergstrom G, and Anderson WP. Renal hemodynamic responses to intrarenal infusion of ligands for the putative angiotensin IV receptor in anesthetized rats. J Cardiovasc Pharmacol 34: 206-211, 1999.
19. Gardiner SM, Kemp PA, March JE, and Bennett T. Regional haemodynamic effects of angiotensin II (3- 8) in conscious rats. Br J Pharmacol 110: 159-162, 1993.
20. Geiger MUF, Herrero H, Zeuzem M, and Piiper A. Involvement of the platelet-derived growth factor receptor in angiotensin II-induced activation of extracellular regulated kinases 1 and 2 in human glomerular mesangial cells. FEBS Lett 472: 129-132, 2000.
21. Gorin Y, Ricono JM, Wagner B, Kim NH, Bhandari B, Choudhury GG, and Abboud HE. Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells. Biochem J 381: 231-239, 2004.
22. Haberl RL, Decker PJ, and Einhaupl KM. Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles. Circ Res 68: 1621-1627, 1991.
23. 1-7 in the kidney. Am J Physiol Renal Physiol 281: F936-F947, 2001.
24. Handa RK. Characterization and signaling of the AT4 receptor in human proximal tubule epithelial (HK-2) cells. J Am Soc Nephrol 12: 440-449, 2001.
25. Inscho EW, Mason MJ, Schroeder AC, Deichmann PC, Stiegler KD, and Imig JD. Agonist-induced calcium regulation in freshly isolated renal microvascular smooth muscle cells. J Am Soc Nephrol 8: 569-579, 1997.
26. Khosla MC, Smeby RR, and Bumpus FM. Structure-activity relationship in angiotensin analogs. In: Handbook of Experimental Pharmacology. XXXVII. Angiotensin, edited by Page IH and Bumpus FM. Berlin: Springer-Verlag, 1974, p. 126-161.
27. 2-angiotensin II in man. Acta Endocrinol (Copenh) 99: 577-584, 1982.
28. 1 receptor activation. J Biol Chem 277: 23107-23110, 2002.
29. Li YD, Block ER, and Patel JM. Activation of multiple signaling modules is critical in angiotensin IV-induced lung endothelial cell proliferation. Am J Physiol Lung Cell Mol Physiol 283: L707-L716, 2002.
30. 1 receptor antagonist. Circ Res 94: 1451-1457, 2004.
31. Loufrani L, Henrion D, Chansel D, Ardaillou R, and Levy BI. Functional evidence for an angiotensin IV receptor in rat resistance arteries. J Pharmacol Exp Ther 291: 583-588, 1999.
32. Petrescu G, Costuleanu M, Slatineanu SM, Costuleanu N, Foia L, and Costuleanu A. Contractile effects of angiotensin peptides in rat aorta are differentially dependent on tyrosine kinase activity. J Renin Angiotensin Aldosterone Syst 2: 180-187, 2001.
33. Ruan X and Arendshort WJ. Calcium entry and mobilization signaling pathways in Ang II-induced renal vasoconstriction in vivo. Am J Physiol Renal Fluid Electrolyte Physiol 270: F398-F405, 1996.
34. Skurk T, Lee YM, Rohrig K, and Hauner H. Effect of angiotensin peptides on PAI-1 expression and production in human adipocytes. Horm Metab Res 33: 196-200, 2001.
35. Swanson GN, Hanesworth JM, Sardinia MF, Coleman JK, Wright JW, Hall KL, Miller-Wing AV, Stobb JW, Cook VI, and Harding JW. Discovery of a distinct binding site for angiotensin II (3- 8), a putative angiotensin IV receptor. Regul Pept 40: 409-419, 1992.
36. van Rodijnen WF, van Lambalgen TA, van Wijhe MH, Tangelder GJ, and Ter Wee PM. Renal microvascular actions of angiotensin II fragments. Am J Physiol Renal Physiol 283: F86-F92, 2002.
37. Wright JW, Krebs LT, Stobb JW, and Harding JW. The angiotensin IV system: functional implications. Front Neuroendocrinol 16: 23-52, 1995.
38. Zhu Z and Arendshort WJ. Angiotensin II-receptor stimulation of cytosolic calcium concentration in cultured renal resistence arterioles. Am J Physiol Renal Fluid Electrolyte Physiol 271: F1239-F1247, 1996.
39. 2 receptors in the hypertensive Ren-2 gene transgenic rat kidney. Hypertension 33: 347-353, 1999.
40. Zhuo JL, Thomas D, Harris PJ, and Skinner SL. The role of endogenous angiotensin II in the regulation of renal haemodynamics and proximal fluid reabsorption in the rat. J Physiol 453: 1-13, 1992.
41. 1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography. Clin Exp Pharmacol Physiol 21: 557-567, 1994.
42. 1 angiotensin II receptors in rat kidney. Renal Physiol Biochem 15: 231-239, 1992.
43. 4 receptors. J Hypertens 16: 2027-2037, 1997.
44. 1 receptor. Hypertension 39: 116-121, 2002.